15-Nov-2019

Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...

more

License to accelerate research, enable testing and development of new drugs

13-Nov-2019

Merck announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an international biotechnology company headquartered in Hamburg, Germany, will use Merck’s CRISPR genome-editing technology to create edited cell lines ...

more

31-Oct-2019

Merck and the German business journal manager magazin presented the Curious Mind Researcher Award in Berlin. Ulrike Kramm (40), a materials scientist, received the prize worth €7,500 in the category “Mobility and Energy”. Computer scientist Xiaoying Zhuang (36) was also awarded € 7,500 for her ...

more

RMB 100 million fund targets startups close to the three business sectors of Merck as well as new businesses

21-Oct-2019

Merck announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced plans to officially open a second innovation hub in Guangzhou in November. “Our RMB 100 million China seed fund underlines our ...

more

Acquisition of FloDesign Sonics marks next step in autologous manufacturing

11-Oct-2019

Merck announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed. “Chimeric antigen receptor T cell therapies, or CAR-T ...

more

12-Sep-2019

Merck expects to achieve sustainable profitable growth in all three business sectors in the coming years. At its Capital Markets Day, the company informed analysts and investors about the progress it has made in implementing its strategy. “In recent years, we have rigorously positioned our ...

more

06-Sep-2019

Merck presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science. The award ceremony took place during the analytical conference Euroanalysis at Istanbul University in ...

more

Net sales growth thanks to organic performance

09-Aug-2019

Merck generated strong net sales growth in the second quarter of 2019, primarily on an organic basis. EBITDA pre grew very strongly and was also driven by organic performance. Merck confirmed its full-year forecast for 2019. “We achieved sales growth in all business sectors and regions. The jump ...

more

07-Aug-2019

Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed. “BSSN Software and the capabilities that it brings ...

more

19-Jul-2019

Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development. “Together with the Broad Institute, we are ...

more